Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating cancer using a combination of entinostat and an anti-CSF-1R antibody

Method of treating cancer using a combination of entinostat and an anti-CSF-1R antibody

US Patent 12168054 · Granted Dec 17, 2024

Estimated economic value: $13,363,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mutant p-hydroxyphenylpyruvate dioxygenase, and coding nucleic acid and use ther2025
Reusable SERS molecule detection apparatus and use method thereof2025
Nucleic acid extraction composition, reagent and kit containing the same and use2025
Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor2025
Kappa opioid receptor peptide amide ligands2025
Selection of patients for combination therapy2024
Selection of patients for combination therapy2024
Covalent peptide binders2024
Anti-PD-1 antibodies2023
Channeled fibers in separation of biologically active nanoparticles2023
Amino alcohol derivative, pharmaceutical composition and application thereof2023
Multifunctional protein2022